• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 31, 2022

    3/31/22 5:25:32 AM ET
    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Multi-Sector Companies
    Miscellaneous
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACTG alert in real time by email

     

    Companies Reporting Before The Bell

    • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

    • Perma-Fix Envirn Servs (NASDAQ:PESI) is likely to report earnings for its fourth quarter.

    • Recruiter.Com Group (NASDAQ:RCRT) is projected to report quarterly loss at $0.38 per share on revenue of $8.77 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is likely to report quarterly loss at $0.01 per share on revenue of $29.80 million.

    • Welltower (NYSE:WELL) is projected to report quarterly loss at $0.03 per share on revenue of $112.79 million.

    • Renalytix (NASDAQ:RNLX) is projected to report quarterly loss at $0.17 per share on revenue of $500.00 thousand.

    • 1847 Goedeker (AMEX:GOED) is projected to report quarterly earnings at $0.05 per share on revenue of $145.00 million.

    • Celsion (NASDAQ:CLSN) is likely to report quarterly loss at $0.90 per share on revenue of $120.00 thousand.

    • Acacia Research (NASDAQ:ACTG) is likely to report quarterly loss at $0.04 per share on revenue of $5.00 million.

    • Affimed (NASDAQ:AFMD) is projected to report quarterly loss at $0.17 per share on revenue of $8.57 million.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is estimated to report earnings for its fourth quarter.

    • Dare Bioscience (NASDAQ:DARE) is likely to report quarterly loss at $0.15 per share on revenue of $1.25 million.

    • Smith-Midland (NASDAQ:SMID) is expected to report earnings for its fourth quarter.

    • Walgreens Boots Alliance (NASDAQ:WBA) is expected to report quarterly earnings at $1.38 per share on revenue of $33.36 billion.

    • Taysha Gene Therapies (NASDAQ:TSHA) is projected to report earnings for its fourth quarter.

    • Jiayin Gr (NASDAQ:JFIN) is likely to report earnings for its fourth quarter.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report quarterly loss at $0.11 per share on revenue of $7.79 million.

    • Blonder Tongue (AMEX:BDR) is estimated to report earnings for its fourth quarter.

    • PDS Biotechnology (NASDAQ:PDSB) is projected to report earnings for its fourth quarter.

    • X Financial (NYSE:XYF) is estimated to report earnings for its fourth quarter.

    • Leju Holdings (NYSE:LEJU) is projected to report earnings for its Fiscal Year 2021.

    • Stratus Properties (NASDAQ:STRS) is expected to report earnings for its fourth quarter.

    • Lottery.com (NASDAQ:LTRY) is likely to report quarterly loss at $0.02 per share on revenue of $28.42 million.

    • Nano X Imaging (NASDAQ:NNOX) is projected to report quarterly loss at $0.33 per share on revenue of $750.00 thousand.

    • Minim (NASDAQ:MINM) is expected to report quarterly loss at $0.03 per share on revenue of $17.77 million.

    • Sharecare (NASDAQ:SHCR) is likely to report quarterly loss at $0.03 per share on revenue of $121.05 million.

    • Nano Dimension (NASDAQ:NNDM) is expected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • SuperCom (NASDAQ:SPCB) is projected to report quarterly loss at $0.10 per share on revenue of $3.20 million.

    • Redwire (NYSE:RDW) is expected to report earnings for its fourth quarter.

    • Digital Brands Group (NASDAQ:DBGI) is estimated to report earnings for its fourth quarter.

    • Ensysce Biosciences (NASDAQ:ENSC) is expected to report quarterly loss at $0.02 per share on revenue of $1.00 million.

    • OMNIQ (NASDAQ:OMQS) is likely to report quarterly loss at $0.41 per share on revenue of $23.34 million.

    • INVO Bioscience (NASDAQ:INVO) is projected to report quarterly loss at $0.22 per share on revenue of $210.00 thousand.

    • Blackboxstocks (NASDAQ:BLBX) is projected to report quarterly loss at $0.05 per share on revenue of $1.53 million.

    • Inhibikase Therapeutics (NASDAQ:IKT) is likely to report quarterly loss at $0.17 per share on revenue of $300.00 thousand.

    • Nuvve Holding (NASDAQ:NVVE) is likely to report quarterly loss at $0.35 per share on revenue of $3.81 million.

    • AgileThought (NASDAQ:AGIL) is likely to report quarterly loss at $0.08 per share on revenue of $42.50 million.

    • Kidpik (NASDAQ:PIK) is likely to report quarterly loss at $0.26 per share on revenue of $5.04 million.

    • Charah Solns (NYSE:CHRA) is projected to report quarterly earnings at $0.06 per share on revenue of $84.11 million.

    • PyroGenesis Canada (NASDAQ:PYR) is likely to report earnings for its fourth quarter.

    • Draganfly (NASDAQ:DPRO) is estimated to report earnings for its fourth quarter.

    • Wejo Gr (NASDAQ:WEJO) is estimated to report quarterly loss at $0.21 per share on revenue of $2.05 million.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its fourth quarter.

    • Statera BioPharma (NASDAQ:STAB) is projected to report earnings for its fourth quarter.

    • Vislink Technologies (NASDAQ:VISL) is estimated to report earnings for its fourth quarter.

    • Arco Platform (NASDAQ:ARCE) is estimated to report quarterly earnings at $0.31 per share on revenue of $84.83 million.

    • Calithera Biosciences (NASDAQ:CALA) is likely to report earnings for its fourth quarter.

    • Aehr Test Systems (NASDAQ:AEHR) is expected to report quarterly earnings at $0.14 per share on revenue of $15.14 million.

    • Chicken Soup for the Soul (NASDAQ:CSSE) is estimated to report quarterly loss at $0.51 per share on revenue of $36.09 million.

    • Lulus Fashion Lounge (NASDAQ:LVLU) is likely to report quarterly loss at $0.07 per share on revenue of $92.75 million.

    • Spero Therapeutics (NASDAQ:SPRO) is projected to report quarterly loss at $0.75 per share on revenue of $4.95 million.

    • Remark Hldgs (NASDAQ:MARK) is likely to report earnings for its fourth quarter.

    • Pulse Biosciences (NASDAQ:PLSE) is likely to report quarterly loss at $0.51 per share on revenue of $870.00 thousand.

    • Reed's (NASDAQ:REED) is expected to report quarterly loss at $0.04 per share on revenue of $13.02 million.

    • VirTra (NASDAQ:VTSI) is expected to report quarterly earnings at $0.05 per share on revenue of $6.14 million.

    • GSE Systems (NASDAQ:GVP) is projected to report earnings for its fourth quarter.

    • Afya (NASDAQ:AFYA) is projected to report quarterly earnings at $0.18 per share on revenue of $104.76 million.

    • BlackBerry (NYSE:BB) is projected to report quarterly loss at $0.04 per share on revenue of $237.17 million.

    • Presidio Property Trust (NASDAQ:SQFT) is likely to report quarterly loss at $0.09 per share on revenue of $5.37 million.

    • Verb Tech (NASDAQ:VERB) is expected to report quarterly loss at $0.10 per share on revenue of $3.18 million.

    • voxeljet (NASDAQ:VJET) is expected to report quarterly loss at $0.04 per share on revenue of $11.10 million.

    • Arcimoto (NASDAQ:FUV) is likely to report quarterly loss at $0.26 per share on revenue of $1.48 million.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is projected to report quarterly loss at $0.04 per share on revenue of $2.82 million.

    • Biocept (NASDAQ:BIOC) is expected to report quarterly loss at $0.19 per share on revenue of $11.11 million.

    • Rekor Systems (NASDAQ:REKR) is likely to report quarterly loss at $0.21 per share on revenue of $2.75 million.

    • Duck Creek Technologies (NASDAQ:DCT) is likely to report quarterly earnings at $0.01 per share on revenue of $72.75 million.

    • GreenBox POS (NASDAQ:GBOX) is expected to report quarterly loss at $0.06 per share on revenue of $9.75 million.

    • Hill International (NYSE:HIL) is expected to report earnings for its fourth quarter.

    • LMP Automotive Holdings (NASDAQ:LMPX) is likely to report earnings for its fourth quarter.

    • Pioneer Power Solutions (NASDAQ:PPSI) is likely to report quarterly loss at $0.06 per share on revenue of $5.97 million.

    • Shapeways Hldgs (NYSE:SHPW) is projected to report quarterly loss at $0.11 per share on revenue of $7.43 million.

    • Greenbrook TMS (NASDAQ:GBNH) is projected to report quarterly loss at $0.40 per share on revenue of $12.70 million.

    • Ncino (NASDAQ:NCNO) is likely to report quarterly loss at $0.09 per share on revenue of $69.31 million.

    • Planet Labs (NYSE:PL) is expected to report earnings for its fourth quarter.

    • Astra Space (NASDAQ:ASTR) is likely to report quarterly loss at $0.25 per share on revenue of $1.17 million.

    • Blend Labs (NYSE:BLND) is expected to report quarterly loss at $0.19 per share on revenue of $82.92 million.

    • Alta Equipment Group (NYSE:ALTG) is likely to report quarterly earnings at $0.04 per share on revenue of $300.40 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACTG
    $ADMP
    $AEHR
    $AFMD

    CompanyDatePrice TargetRatingAnalyst
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Inhibikase Therapeutics Inc.
    $IKT
    1/21/2026$6.00Buy
    BofA Securities
    Afya Limited
    $AFYA
    1/16/2026$16.00Buy → Neutral
    UBS
    Afya Limited
    $AFYA
    1/7/2026$22.00Overweight → Neutral
    Analyst
    Inhibikase Therapeutics Inc.
    $IKT
    12/26/2025$8.00Buy
    H.C. Wainwright
    Redwire Corporation
    $RDW
    12/19/2025Sector Weight
    KeyBanc Capital Markets
    Welltower Inc.
    $WELL
    12/18/2025$205.00Overweight → Neutral
    Analyst
    nCino Inc.
    $NCNO
    12/17/2025Neutral
    BTIG Research
    More analyst ratings

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP Contactor Business Unit Sporck Alistair N sold $82,716 worth of shares (3,000 units at $27.57), decreasing direct ownership by 11% to 25,153 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    2/10/26 4:17:52 PM ET
    $AEHR
    Electrical Products
    Industrials

    EVP of Strategic Initiatives Centofanti Louis F gifted 1,200 shares, decreasing direct ownership by 0.55% to 217,565 units (SEC Form 4)

    4 - PERMA FIX ENVIRONMENTAL SERVICES INC (0000891532) (Issuer)

    2/10/26 2:46:50 PM ET
    $PESI
    Environmental Services
    Industrials

    Officer Rajavelu Esther sold $207,484 worth of shares (87,917 units at $2.36), decreasing direct ownership by 8% to 1,012,091 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/9/26 9:31:37 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    SEC Filings

    View All

    Welltower Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - WELLTOWER INC. (0000766704) (Filer)

    2/10/26 4:05:53 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    Acacia Research Corporation (Acacia Tech) filed SEC Form 8-K: Leadership Update

    8-K - ACACIA RESEARCH CORP (0000934549) (Filer)

    2/6/26 4:19:02 PM ET
    $ACTG
    Multi-Sector Companies
    Miscellaneous

    SEC Form 6-K filed by Afya Limited

    6-K - Afya Ltd (0001771007) (Filer)

    2/6/26 8:11:55 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Chief Executive Officer Heilbron Jack Kendrick bought $28,200 worth of Common Stock - Series A (10,000 units at $2.82) (SEC Form 4)

    4 - Presidio Property Trust, Inc. (0001080657) (Issuer)

    12/30/25 11:39:41 AM ET
    $SQFT
    Real Estate Investment Trusts
    Real Estate

    Chief Executive Officer Heilbron Jack Kendrick bought $14,780 worth of Preferred Stock - Series D (1,000 units at $14.78) (SEC Form 4)

    4 - Presidio Property Trust, Inc. (0001080657) (Issuer)

    12/30/25 11:38:42 AM ET
    $SQFT
    Real Estate Investment Trusts
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    FDA Approval for XACIATO issued to DARE BIOSCIENCE INC

    Submission status for DARE BIOSCIENCE INC's drug XACIATO (ORIG-1) with active ingredient CLINDAMYCIN PHOSPHATE has changed to 'Approval' on 12/07/2021. Application Category: NDA, Application Number: 215650, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/7/21 12:35:25 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Welltower Issues Business Update

    TOLEDO, Ohio, Feb. 10, 2026 /PRNewswire/ -- Welltower® Inc. (NYSE:WELL) has issued the following business update which can be found at: https://welltower.com/feb-10-26-business-update About Welltower Welltower Inc. (NYSE:WELL), an S&P 500 company, is positioned at the center of the silver economy, focusing on rental housing for aging seniors across the United States, United Kingdom, and Canada. Our portfolio of 2,000+ seniors and wellness housing communities are positioned at the intersection of housing and hospitality, creating vibrant communities for mature renters and older adults. We believe our real estate portfolio is unmatched, located in highly attractive micromarkets with stunning

    2/10/26 4:07:00 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    Welltower Reports Fourth Quarter 2025 Results

    TOLEDO, Ohio, Feb. 10, 2026 /PRNewswire/ -- Welltower Inc. (NYSE:WELL) today announced results for the quarter ended December 31, 2025. Fourth Quarter and Other Recent Highlights Reported net income attributable to common stockholders of $0.14 per diluted shareReported quarterly normalized funds from operations attributable to common stockholders of $1.45 per diluted share, an increase of 28.3% over the prior yearReported total portfolio year-over-year same store NOI ("SSNOI") growth of 15.0%, driven by SSNOI growth in our Seniors Housing Operating ("SHO") portfolio of 20.4%SH

    2/10/26 4:05:00 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    BofA Securities initiated coverage on Inhibikase Therapeutics with a new price target

    BofA Securities initiated coverage of Inhibikase Therapeutics with a rating of Buy and set a new price target of $6.00

    1/21/26 8:55:17 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Afya downgraded by UBS with a new price target

    UBS downgraded Afya from Buy to Neutral and set a new price target of $16.00

    1/16/26 8:27:35 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Leadership Updates

    Live Leadership Updates

    View All

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    Lulus Appoints Heidi Crane as Permanent Chief Financial Officer

    CHICO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU) today announced the appointment of Heidi Crane as its permanent Chief Financial Officer ("CFO"), effective February 4, 2026. Ms. Crane previously served as the Company's fractional CFO since October 13, 2025. "We're thrilled to have Heidi officially join our team as permanent CFO," said Crystal Landsem, CEO of Lulus. "After working closely with us in a fractional capacity, Heidi has demonstrated exceptional financial discipline, strategic insight, and a deep understanding of our business. Heidi's transition to Lulus' permanent CFO was a natural next step, and we'r

    2/5/26 4:03:00 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    KNOREX Appoints Michael Sun as Chief Financial Officer

    Senior finance executive Michael Sun named CFO KNOREX Ltd. (NYSE:KNRX) ("KNOREX" or the "Company"), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its Board of Directors has appointed Ning (Michael) Sun as Chief Financial Officer ("CFO"), effective January 22, 2026. The appointment strengthens the Company's executive leadership team as KNOREX builds internal infrastructure to support its next phase of accelerated growth as a public company. "Michael brings deep capital markets and public-company experience that KNOREX needs at this stage of our development," said Dr. Justin Choo, CEO and Chairman of KNOREX. "As we gain commer

    1/23/26 8:30:00 AM ET
    $JFIN
    $KNRX
    $SFUN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Financials

    Live finance-specific insights

    View All

    Welltower Reports Fourth Quarter 2025 Results

    TOLEDO, Ohio, Feb. 10, 2026 /PRNewswire/ -- Welltower Inc. (NYSE:WELL) today announced results for the quarter ended December 31, 2025. Fourth Quarter and Other Recent Highlights Reported net income attributable to common stockholders of $0.14 per diluted shareReported quarterly normalized funds from operations attributable to common stockholders of $1.45 per diluted share, an increase of 28.3% over the prior yearReported total portfolio year-over-year same store NOI ("SSNOI") growth of 15.0%, driven by SSNOI growth in our Seniors Housing Operating ("SHO") portfolio of 20.4%SH

    2/10/26 4:05:00 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 7647402. A live and recorded webcast of the event will be available on the Pulse Bioscie

    2/4/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Nano Dimension Adopts Limited Duration Shareholder Rights Agreement

    WALTHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension" or the "Company"), a leader in digital manufacturing solutions, today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights agreement (the "Rights Agreement"). The adoption of the Rights Agreement is intended to protect the long-term interests of Nano Dimension and all Nano Dimension's holders of American Depository Shares ("ADSs") and enable them to realize the full potential value of their investment in the Company. The Rights Agreement is designed to reduce the likelihood that any entity, person or group would gain control of, or exert si

    2/2/26 6:30:00 PM ET
    $NNDM
    Electrical Products
    Technology

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Smith-Midland Corporation

    SC 13D/A - SMITH MIDLAND CORP (0000924719) (Subject)

    12/10/24 3:10:37 PM ET
    $SMID
    Building Materials
    Industrials

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED